Question follow-through · 28289

Givinostat

To ask the Secretary of State for Health and Social Care, what steps his Department is taking with NHS England to ensure that eligible patients have access to Givinostat employee assistance programmes.

answeredDepartment of Health and Social Care

About this written question

A written question asks a government minister for information in writing. Parliament publishes the question and any answer.

Answering body: Department of Health and Social Care
Tabled: 3 Feb 2025
Target answer date: 5 Feb 2025
Answer: 10 Feb 2025 · 7 calendar days after tabling

Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.

Votes on this topic

Terminally Ill Adults (End of Life) Bill: Second Reading · 11 Sept 2026
Health Bill: Report Stage: Amendment 1 · 8 Sept 2026
Health Bill: Report Stage: New Clause 143 · 8 Sept 2026

These Commons divisions share a topic label. The question did not necessarily lead to a vote.

Recorded timeline

3 Feb 2025
Question tabled
To ask the Secretary of State for Health and Social Care, what steps his Department is taking with NHS England to ensure that eligible patients have access to Givinostat employee assistance programmes.
5 Feb 2025
Target answer date
Date supplied by the official written-questions record.
10 Feb 2025
Answer published
ITF Pharma UK, the United Kingdom marketing authorisation holder for givinostat, is providing access to givinostat through a type of compassionate use scheme called an Early Access Programme (EAP). Under the EAP, givinostat is free to both patients taking...

Open official record

Official data retrieved 28 Sept 2026.

Later records

Possible follow-up questions

Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.